@article{a344bdedc1a240f1a45f30cb4c4f3d6a,
title = "Clinical challenges related to novel oral anticoagulants: Drug-drug interactions and monitoring",
keywords = "Interaction, Novel oral anticoagulants, Pulmonary embolism, acenocoumarol, acetylsalicylic acid, amino terminal pro brain natriuretic peptide, amoxicillin plus clavulanic acid, anticoagulant agent, antivitamin K, apixaban, C reactive protein, ciprofloxacin, dabigatran, rifampicin, rivaroxaban, troponin T, acute coronary syndrome, aged, anticoagulant therapy, case report, coronary artery bypass graft, drug drug interaction, drug monitoring, drug substitution, dyspnea, electrocardiography, female, femur fracture, atrial fibrillation, hip surgery, human, laboratory test, letter, lung embolism, prothrombin time, sepsis, thorax pain, thorax radiography, thromboembolism, venous thromboembolism, wound infection",
author = "Renske Altena and {van Roon}, Eric and Richard Folkeringa and {de Wit}, Harry and Mels Hoogendoorn",
year = "2014",
month = feb,
day = "1",
doi = "10.3324/haematol.2013.097287",
language = "English",
volume = "99",
pages = "e26--e27",
journal = "Haematologica",
issn = "0390-6078",
publisher = "FERRATA STORTI FOUNDATION",
number = "2",
}